Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - PARMAR KUSH

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for PARMAR KUSH

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 2,418,548
(Indirect)
View
2019-05-16
Sale
2019-05-20
4:24 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
615,000 $21.47 $13,204,050 5,314,484
(Indirect)
View
2018-12-10
Sale
2018-12-12
8:10 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
15,575 $26.01 $405,029 5,904,884
(Indirect)
View
2018-11-23
Sale
2018-11-27
6:09 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
29,682 $20.04 $594,709 5,919,836
(Indirect)
View
2018-11-16
Sale
2018-11-20
5:05 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
525,900 $20.2 $10,623,180 5,948,331
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 2,418,548
(Indirect)
View
2019-09-24
Gift
2019-09-26
6:54 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
1,700 $0 1,775
(Direct)
View
2019-09-16
Other
2019-09-18
9:33 pm
N/A
N/A
ARVINAS Inc ARVN PARMAR KUSH
Director
3,475 $0 3,475
(Direct)
View
2019-06-06
Option Award
2019-06-10
5:09 pm
N/A
2029-06-06
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
15,580 $19.51 15,580
(Direct)
View
2019-05-23
Option Award
2019-05-28
5:08 pm
N/A
2029-05-22
ARVINAS Inc ARVN PARMAR KUSH
Director
12,923 $22.06 12,923
(Direct)
View
2018-06-19
Option Award
2018-06-21
6:39 pm
2019-06-19
2028-06-19
scPharmaceuticals Inc. SCPH PARMAR KUSH
Director
6,124 $5.53 6,124
(Direct)
View
2018-06-08
Option Award
2018-06-08
5:23 pm
N/A
2028-06-08
Audentes Therapeutics Inc. BOLD PARMAR KUSH
Director
10,000 $38.65 10,000
(Direct)
View
2018-04-02
Conversion
2018-04-04
7:09 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
5,392,037 $0 6,722,076
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
5,392,037 $0 6,722,076
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
4,204,502 $0 6,722,076
(Indirect)
View
2018-04-02
Conversion
2018-04-04
4:24 pm
N/A
N/A
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
1,187,535 $0 6,722,076
(Indirect)
View
2018-03-27
Option Award
2018-03-29
7:27 pm
N/A
2028-03-27
Homology Medicines Inc. FIXX PARMAR KUSH
Director, 10% Owner
31,160 $16 31,160
(Direct)
View